• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于图谱法和个体患者剂量分布的多变量分析评估 3 级口腔和咽喉吞咽困难的风险。

Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.

机构信息

Department of Clinical Oncology, Royal Marsden Hospital, Sutton and London, UK.

Department of Clinical Oncology, Royal Marsden Hospital, Sutton and London, UK; The Institute of Cancer Research, London, UK.

出版信息

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):507-15. doi: 10.1016/j.ijrobp.2015.07.2263. Epub 2015 Jul 17.

DOI:10.1016/j.ijrobp.2015.07.2263
PMID:26460992
Abstract

PURPOSE

The study aimed to apply the atlas of complication incidence (ACI) method to patients receiving radical treatment for head and neck squamous cell carcinomas (HNSCC), to generate constraints based on dose-volume histograms (DVHs), and to identify clinical and dosimetric parameters that predict the risk of grade 3 oral mucositis (g3OM) and pharyngeal dysphagia (g3PD).

METHODS AND MATERIALS

Oral and pharyngeal mucosal DVHs were generated for 253 patients who received radiation (RT) or chemoradiation (CRT). They were used to produce ACI for g3OM and g3PD. Multivariate analysis (MVA) of the effect of dosimetry, clinical, and patient-related variables was performed using logistic regression and bootstrapping. Receiver operating curve (ROC) analysis was also performed, and the Youden index was used to find volume constraints that discriminated between volumes that predicted for toxicity.

RESULTS

We derived statistically significant dose-volume constraints for g3OM over the range v28 to v70. Only 3 statistically significant constraints were derived for g3PD v67, v68, and v69. On MVA, mean dose to the oral mucosa predicted for g3OM and concomitant chemotherapy and mean dose to the inferior constrictor (IC) predicted for g3PD.

CONCLUSIONS

We have used the ACI method to evaluate incidences of g3OM and g3PD and ROC analysis to generate constraints to predict g3OM and g3PD derived from entire individual patient DVHs. On MVA, the strongest predictors were radiation dose (for g3OM) and concomitant chemotherapy (for g3PD).

摘要

目的

本研究旨在将并发症发生率图谱(ACI)方法应用于接受头颈部鳞状细胞癌(HNSCC)根治性治疗的患者,基于剂量-体积直方图(DVH)生成约束条件,并识别预测 3 级口腔黏膜炎(g3OM)和咽功能障碍(g3PD)风险的临床和剂量学参数。

方法和材料

为 253 例接受放疗(RT)或放化疗(CRT)的患者生成口腔和咽黏膜 DVH,用于生成 g3OM 和 g3PD 的 ACI。使用逻辑回归和自举法对剂量学、临床和患者相关变量的影响进行多变量分析(MVA)。还进行了受试者工作特征曲线(ROC)分析,并使用约登指数寻找区分毒性预测体积的体积约束。

结果

我们得出了在 v28 到 v70 范围内预测 g3OM 的统计学显著剂量-体积约束。仅为 g3PD v67、v68 和 v69 得出了 3 个统计学显著的约束。在 MVA 中,口腔黏膜的平均剂量预测 g3OM,同期化疗预测 g3PD,下食管括约肌(IC)的平均剂量预测 g3PD。

结论

我们使用 ACI 方法评估 g3OM 和 g3PD 的发生率,并使用 ROC 分析从整个个体患者 DVH 生成预测 g3OM 和 g3PD 的约束条件。在 MVA 中,最强的预测因子是放射剂量(用于 g3OM)和同期化疗(用于 g3PD)。

相似文献

1
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions.基于图谱法和个体患者剂量分布的多变量分析评估 3 级口腔和咽喉吞咽困难的风险。
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):507-15. doi: 10.1016/j.ijrobp.2015.07.2263. Epub 2015 Jul 17.
2
Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.人乳头瘤病毒相关口咽鳞状细胞癌减量化放化疗患者报告的口干症和吞咽困难的剂量学预测因素
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1022-1027. doi: 10.1016/j.ijrobp.2017.03.034. Epub 2017 Mar 27.
3
Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer.头颈部癌症患者接受诱导化疗后同期放化疗致急性口腔黏膜炎和吞咽困难的剂量反应分析。
Radiother Oncol. 2012 Apr;103(1):88-91. doi: 10.1016/j.radonc.2011.12.027. Epub 2012 Jan 24.
4
Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.头颈部癌症患者接受Hypofractionated 加速放射治疗的化放疗后口腔和咽部黏膜反应的特点。
Radiother Oncol. 2010 Oct;97(1):86-91. doi: 10.1016/j.radonc.2010.08.013. Epub 2010 Sep 7.
5
Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529.肛管癌剂量勾画调强放射治疗中与放射治疗相关的胃肠道毒性的预测因素:NRG肿瘤学RTOG 0529的二次分析
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):400-408. doi: 10.1016/j.ijrobp.2017.02.005. Epub 2017 Feb 13.
6
Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.剂量强化的低分割调强放疗同步西妥昔单抗治疗中期头颈部鳞状细胞癌。
Acta Oncol. 2015 Jan;54(1):88-98. doi: 10.3109/0284186X.2014.958528. Epub 2014 Oct 3.
7
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.头颈部调强适形放疗后长期吞咽功能障碍的候选剂量学预测因素。
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1356-65. doi: 10.1016/j.ijrobp.2009.10.002. Epub 2010 Jun 18.
8
IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.调强放疗同步加量推量照射和同期化疗治疗局部晚期头颈部鳞状细胞癌。
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e845-52. doi: 10.1016/j.ijrobp.2010.10.021. Epub 2010 Dec 16.
9
Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer.头颈部癌症化放综合治疗后咽缩肌剂量与患者生活质量及迟发性吞咽困难的相关性。
Radiother Oncol. 2009 Dec;93(3):539-44. doi: 10.1016/j.radonc.2009.09.017. Epub 2009 Oct 31.
10
Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.头颈部癌放化疗后咽结构的容积变化。
Laryngoscope. 2020 Mar;130(3):597-602. doi: 10.1002/lary.28164. Epub 2019 Jul 1.

引用本文的文献

1
A multi-center, multi-organ, multi-omic prediction model for treatment-induced severe oral mucositis in nasopharyngeal carcinoma.一种用于预测鼻咽癌治疗引起的严重口腔黏膜炎的多中心、多器官、多组学预测模型。
Radiol Med. 2025 Feb;130(2):161-178. doi: 10.1007/s11547-024-01901-z. Epub 2024 Nov 21.
2
Predicting radiotherapy response, Toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose-volume constraints development: a study protocol.使用剂量-体积限制开发预测四肢软组织肉瘤的放疗反应、毒性和与生活质量相关的功能结局(PredicT):研究方案。
BMJ Open. 2024 Aug 9;14(8):e083617. doi: 10.1136/bmjopen-2023-083617.
3
Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review.
头颈部癌放化疗引起口腔黏膜炎和吞咽困难的预测因素:一项范围综述
Cancers (Basel). 2023 Dec 4;15(23):5705. doi: 10.3390/cancers15235705.
4
Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit.质子治疗与口腔及口咽癌的口腔黏膜炎:结果、剂量学和 NTCP 获益。
Radiat Oncol. 2023 Jul 19;18(1):121. doi: 10.1186/s13014-023-02317-1.
5
Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis.基于 F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)反应的降阶梯确定性放化疗治疗 p16+口咽癌的 2 期试验的初步可行性和急性毒性结果:计划的中期分析。
Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):171-180. doi: 10.1016/j.ijrobp.2023.03.043. Epub 2023 Mar 16.
6
Postoperative radiotherapy for supraglottic cancer on real-world data: can we reduce dose to lymph node levels?基于真实世界数据的声门上型癌症术后放疗:我们能否降低淋巴结水平的剂量?
Radiat Oncol. 2023 Feb 22;18(1):35. doi: 10.1186/s13014-023-02228-1.
7
Delineation of Oral Mucosa as a Pseudo-Organ-at-Risk May Lead to a Decrease in the Incidence of Oral Mucositis: A Dosimetric Analysis of Intensity-Modulated Radiation Therapy Plans in Head and Neck Cancers.将口腔黏膜划定为一个伪危及器官可能会导致口腔黏膜炎发病率的降低:头颈部癌调强放射治疗计划的剂量学分析
Cureus. 2022 Mar 31;14(3):e23716. doi: 10.7759/cureus.23716. eCollection 2022 Mar.
8
Assessing the robustness of artificial intelligence powered planning tools in radiotherapy clinical settings-a phantom simulation approach.评估人工智能驱动的放疗临床计划工具的稳健性——一种体模模拟方法。
Quant Imaging Med Surg. 2021 Dec;11(12):4835-4846. doi: 10.21037/qims-21-51.
9
Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.局部晚期头颈部癌症中的预防性胃造口术:一项针对放射肿瘤学家的全国性调查结果。
BMC Cancer. 2021 Jun 2;21(1):656. doi: 10.1186/s12885-021-08348-9.
10
Predictive Model and Precaution for Oral Mucositis During Chemo-Radiotherapy in Nasopharyngeal Carcinoma Patients.鼻咽癌患者放化疗期间口腔黏膜炎的预测模型及预防措施
Front Oncol. 2020 Nov 5;10:596822. doi: 10.3389/fonc.2020.596822. eCollection 2020.